Figure 2From: A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapyBiodistribution of111In-anti-ROBO1 in HepG2 xenograft mice. Results represent the calculated percentages of the injected dose per gram of tissue (% ID/g).Back to article page